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Background: Diabetes is a significant risk factor for developing West Nile virus (WNV)-associated encephalitis
(WNVE) in humans, the leading cause of arboviral encephalitis in the United States. Using a diabetic mouse model
(db/db), we recently demonstrated that diabetes enhanced WNV replication and the susceptibility of mice to WNVE.
Herein, we have examined immunological events in the brain of wild type (WT) and db/db mice after WNV
infection. We hypothesized that WNV-induced migration of protective leukocytes into the brain is attenuated in the
presence of diabetes, leading to a high viral load in the brain and severe disease in diabetic mice.
Methods: Nine-week old C57BL/6 WT and db/db mice were infected with WNV. Leukocyte infiltration, expression of
cell adhesion molecules (CAM), neuroinflammatory responses, activation of astrocytes, and neuronal death were
analyzed using immunohistochemistry, qRT-PCR, flow cytometry, and western blot.
Results: We demonstrate that infiltration of CD45+ leukocytes and CD8+T cells was significantly reduced in the
brains of db/db mice, which was correlated with attenuated expression of CAM such as E-selectin and ICAM-1. WNV
infection in db/db mice was associated with an enhanced inflammatory response in the brain. mRNA and protein
levels of key chemokines such as CXCL10, CXCL1, CCL2, CCL5, CCL3, and G-CSF, and cytokines such as IL-1β, TNF,
IL-6, IFNγ, and IL-1α were significantly elevated in the brains of db/db mice compared to WT mice. Elevated levels of
cytokines also correlated with increased astrocytes activation and neuronal damage in the brains of db/db mice.
Conclusion: These data suggest that reduced leukocytes recruitment, in part, due to lower levels of CAM results in
failure to clear WNV infection from the brain leading to increased production of inflammatory molecules, which
mediates increased neuronal death and mortality in db/db mice. This is the first study to elucidate the expression of
CAM and their correlation with the migration of leukocytes, specifically cytotoxic CD8+ T cells, in increasing disease
severity in the diabetic mouse model.
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Type 2 diabetes is associated with an impaired immune
response and increased susceptibility to various pathogens
[1,2]. Diabetes inhibits important aspects of leukocyte
function including adhesion, chemotaxis and phagocytosis,
oxidative burst, and intracellular killing [2-5]. Diabetes is
also associated with an enhanced inflammatory response
to infections [6,7]. It is known that diabetes adversely af-
fects leukocyte adherence and transendothelial migration.
Several studies have demonstrated that the adhesion and
migration of neutrophils and monocytes in response to
various chemotactic stimuli is significantly reduced in
diabetic patients compared to non-diabetic controls [3,8,9].
It has also been demonstrated that diabetes results in atten-
uated upregulation of cell adhesion molecules (CAM) and
their ligands, such as intercellular cell adhesion molecule 1
(ICAM-1), E-selectin, and macrophage antigen-1 after vari-
ous stimuli such as lipopolysaccharides (LPS) [3,10,11].
However the effect of diabetes on the expression of CAM
and the migration of leukocytes, specifically across the
blood-brain barrier (BBB), in response to viral infections
such as West Nile virus (WNV) remains largely unknown.
Moreover, the effect of diabetes on the migration of cyto-
toxic CD8+ T cells, important cells in protection against
viral infections, has never been studied.
WNV, a mosquito-borne Flavivirus, belonging to the
family Flaviviridae, that causes lethal encephalitis, has
emerged as a significant cause of viral encephalitis in the
United States [12]. Since its introduction to North
America in 1999, outbreaks of WNV fever (WNF) and
encephalitis (WNVE) have occurred in regions through-
out United States. Up to 70% of the survivors of WNV
neuroinvasive disease experience persistent neurological
deficits after infection [13]. There are no therapeutic
agents or vaccines approved for use against WNV infec-
tion in humans. WNVE occurs more frequently in elderly
and in persons with a compromised immune system,
hypertension and Type 2 diabetes [14]. Epidemiological
and experimental data suggests that diabetes is associated
with an increased risk of WNVE [15-19], and that patients
with diabetes are four times more likely to develop WNVE
than WNF, which is significantly more than other factors
such as old age, male gender and hypertension [20,21]. It
has been reported that a higher proportion of patients
with WNV infection had hyperglycemia on admission
to the hospital. Moreover, persons with diabetes are also
most likely to have persistent symptoms after WNV in-
fection [22,23]. Despite its public health importance,
the neuropathogenesis of WNV infection in the diabetic
population is largely unknown.
WNVE is characterized by neuronal death, activation
of glial cells, and infiltration of leukocytes in the perivas-
cular space and parenchyma [24-26]. A robust induction
of antiviral immune responses is critical for the controlof WNV infection in the periphery and brain. Antiviral
type I interferon (IFN-α and -β) production is essential in
suppressing viral titers in the brain and peripheral organs
[27]. The induction of WNV-specific immunoglobulins
(IgM and IgG) is essential for suppressing viremia and
virus dissemination [28]. The migration of leukocytes into
the brain is essential for controlling WNV infection in the
brain [25,29]. CD8+ T cells are essential for protection
against WNV infection by clearing the virus in the brain
[30]. An absence of CD8+ T cells results in unrestricted
WNV replication and increased neuronal death because
of the high cytopathic potential of WNV [24,30]. WNV-
induced expression of CAM, such as ICAM-1, and pro-
inflammatory molecules such as tumor necrosis factor
(TNF) and CXCL10 promote the trafficking of leukocytes
into the brain [29,31,32].
We have previously demonstrated, using the diabetic
mouse model db/db, that diabetes enhanced the suscepti-
bility of mice to WNV disease and suppressed virus clear-
ance in serum, peripheral tissues, and brains of db/db
mice when compared to wild type (WT) mice [19].
These observations were associated with a significant
delay in the induction of antiviral immune responses
(IFN-α, IgM, and IgG) and an increase in the pro-
inflammatory responses in the serum of db/db mice. In
this study, we have analyzed the immunological events in
the brains of WT and db/db mice after WNV infection in
order to understand the immune mechanisms underlying
increased WNV disease severity in diabetics.
Methods
Animal experiments
Male nine-week-old C57BL/6 J-Leprdb/Leprdb (db/db)
mice and C57BL/6 J (WT) mice were purchased from
The Jackson Laboratory (Bar Harbor, Maine, United
States). Animals were housed four per cage and allowed
to eat and drink freely. The animal suite was maintained
at 72°F, at 45% humidity, and on 12 hour light and dark
cycles. Sawdust bedding was provided along with paper
towels. Trained and certified personnel conducted all
the animal experiments. This study was approved by the
University of Hawaii Institutional Animal Care and Use
Committee (IACUC) (protocol number 10-948), and
was conducted in strict accordance with guidelines
established by the National Institutes of Health and the
University of Hawaii IACUC.
After acclimatization for one week, WT and db/db
mice were inoculated via the footpad route with 10
plaque forming units (PFU) of WNV (NY99) or phosphate
buffered saline (PBS, mock) and at days 4, 6, and 8 after
infection. Mice were anesthetized using isoflurane and
perfused with cold PBS as described previously [19,33,34].
Brains were harvested and flash frozen in 2-methylbutane
(Sigma, St. Louis, Missouri, United States) and stored at
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the brain between days 4 and 6 after footpad inoculation
and peak virus load is observed at day 8 after infection
[34], therefore, brains were harvested at days 4, 6, and 8
after infection.
Alternatively, mice were perfused with PBS followed
by 4% paraformaldehyde (PFA) and brains were har-
vested, cryoprotected in 30% sucrose (Sigma, St. Louis,
Missouri, United States), and embedded in the optimum
cutting temperature (OCT) as described previously [34].
One half of the frozen brain tissues were weighed and
homogenized in a bullet blender using glass or zirconium
beads, and a plaque assay was conducted as described
previously [19].
Quantitation by qRT-PCR and western blot
One half of the frozen brain tissues were powdered over
dry ice to obtain a homogenous sampling and an aliquot
of the frozen brain powder was used to extract total
RNA and protein. The mRNA levels of multiple host
genes were determined using qRT-PCR and the fold-Table 1 Primer sequences used for qRT-PCR

























*bp, base pair; #Tm, Melting temperature.change in infected brains compared to mock brains was
calculated after normalizing to the β-actin gene as de-
scribed previously [34-36]. The primer sequences and
annealing temperatures used for qRT-PCR are listed in
Table 1. Total cellular protein was extracted from the
brain and 20 to 30 μg protein was separated on SDS-
PAGE, transferred onto nitrocellulose membrane and
incubated overnight with polyclonal antibodies against
ICAM-1, E-selectin, vascular cell adhesion molecule 1
(VCAM-1) (Santa Cruz, Dallas, Texas, United States)
and β-actin (Sigma, St. Louis, Missouri, United States)
as described previously [34,35,37]. Following incubation
with secondary antibodies conjugated with IRDye 800
and IRDye 680 (Li-Cor Biosciences, Lincoln, Nebraska
United States), the membranes were scanned using the
Odyssey infrared imager (Li-Cor Biosciences, Lincoln,
Nebraska United States).
Immunohistochemistry
Sagittal sections of 10-μm thickness were cut from the
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anti-CD8-APC (eBiosciences, San Diego, California,
United States) overnight at 4°C as described previously
[34,37]. Additionally, tissue sections were also incu-
bated with primary antibodies against glial fibrillary
acidic protein (GFAP) (DakoCytomation, Carpinteria,
California, United States), NeuN (Millipore, Billerica,
Massachusetts, United States), E-selectin, ICAM-1,
VCAM-1 (Santa Cruz, Dallas, Texas, United States)
and von Willebrand factor (vWF) (Abcam, Cambridge,
Massachusetts, United States) overnight at 4°C followed
by Alexa Fluor 546 or Alexa Fluor 488 conjugated second-
ary antibody as described previously [34]. Terminal deoxy-
nucleotidyl transferase dUTP nick end labeling (TUNEL)
staining was conducted using an in situ cell death detec-
tion kit (Roche, Indianapolis, Indiana, United States) as
described previously [38]. Images were acquired using the
Zeiss Axiovert 200 fluorescent microscope (Carl Zeiss
Microscopy, Thornwood, New York, United States).
Flow cytometric analysis of infiltrated immune cells in the
brain and spleen
The brains and spleens from three WT and db/db mice
(two independent experiments, a total of six mice per
group) were isolated, pooled and homogenized using a
Miltenyi gentle MACS cell dissociator (Miltenyi Biotec,
San Diego, California, United States). Infiltrated leukocytes
were isolated by discontinuous Percoll gradient centrifuga-
tion and quantitated from the brain of WT and db/db
mice as described previously [34,37]. Cells were counted
and washed with 1 × fluorescence activated cell sorter
buffer (0.5% BSA and 2 mM ethylenediaminetetraacetic
acid). To identify for CD45+, CD11b+, CD3+, CD4+ and
CD8+ cell populations, cells were stained using fluorescein
isothiocyanate (FITC)-conjugated anti-CD45, phycoerythrin
(PE) Cy7-conjugated anti-CD11b, PE-conjugated anti-CD3,
PE Texas Red-conjugated anti-CD4 and allophycocyanin
(APC)-conjugated anti-CD8 antibodies (eBiosciences, San
Diego, California, United States) for 30 minutes at 4°C and
then fixed with 4% PFA at 4°C for 15 minutes. Fluorescence
minus one samples were prepared for detecting any
spillover from other channel. Samples were analyzed by
multi-color flow cytometry using FACS Aria and data
were analyzed using FlowJo software (version 9.4.11)
(TreeStar, Ashland, Oregon, United States) as described
previously [34,37].
Measurement of cytokines and chemokines
Brains were weighed and homogenized in a bullet
blender (Next Advance, Averill Park, New York, United
States) using glass beads as described previously [19,34].
The levels of cytokines and chemokines were measured
in the brain homogenates by multiplex immunoassay
using MILLIPLEX MAP Mouse Cytokine/Chemokine kit(Millipore, Billerica, Massachusetts, United States) as
described previously [34].
PCR array
The expression profile of multiple cytokines, chemokines
and their receptors in the brains of mock- and WNV-
infected WT and db/db mice was analyzed using a com-
mercial RT2 Profiler inflammatory cytokines and receptors
PCR Array (SABiosciences, Valencia, California, United
States, Catalogue number: PAMM-011Z) as described
previously [34]. cDNA from four animals from each
group was pooled. The fold-change in infected brains as
compared to mock was calculated after normalizing to
the housekeeping genes.
Statistical analysis
Unpaired student t-test using GraphPad Prism 5.0
(GraphPad Software, La Jolla, California, United States)
was used to calculate P values of difference. For multiplex
immunoassay, two-way analysis of variance (ANOVA) with
the post hoc Bonferroni test was used to calculate P values.
Differences of p < 0.05 were considered significant.
Results
Leukocyte infiltration in the brains of db/db mice after
WNV infection
WT and db/db mice brain tissues were initially examined
for histopathological changes following WNV infection.
Hematoxylin and eosin (H & E) staining of brain sections
from the WT mice demonstrated leukocyte infiltration
along the meninges at day 8 after infection (Figure 1A). In
contrast, fewer leukocytes were observed in the meninges
of WNV-infected db/db mice. This observation was fur-
ther confirmed by direct immunohistochemical analysis
of the CD45 and CD8 antigen, which revealed markedly
reduced staining of CD45 and CD8 positive cells in the
db/db mice brains when compared with WT mice at
day 8 after infection (Figure 1A). We further quanti-
tated the CD45 and CD8 positive cells in the brain sec-
tions from four independent mice in each group. The
average total cell number from 15 different brain areas
per section (total 2 brain sections per mice) are depicted
in Figure 1B. The number of CD45 and CD8 positive
cells in db/db mice was significantly lower than in WT
mice (P <0.05). We then measured WNV viral load in
the brains of WT and db/db mice using a plaque assay.
In contrast to leukocyte infiltration, significantly higher
virus titer was observed in db/db mice brains when
compared to the WT mice brains at day 8 after infection
(Figure 1C, P >0.05).
Furthermore, we compared the mRNA expression
levels of CD45, CD4, CD8, and CD11b in the brains of
WT and db/db mice at days 6 and 8 after infection using
qRT-PCR. As expected, mRNA expression of CD45,
Figure 1 Infiltration of leukocytes and viral load in the brains of WT and db/db mice after WNV infection. (A) Cryopreserved brain
sections from WNV-infected WT and db/db mice at day 8 after infection were stained with hematoxylin and eosin (H & E) and antibodies against
CD45 (Green, white arrows and enlarged inset of the arrowed box) and CD8 (Red, white arrows and enlarged inset of the arrowed box). Black
arrows and enlarged inset of the arrowed box on the H & E stained sections identify leukocytes infiltrating into the meninges of the WT brains.
The photomicrographs demonstrate representative images obtained from two independent experiments (n = 4 per group). Bars, 20 μm.
(B) Quantitative representation of total numbers of CD45 and CD8 positive cells from 15 different brain areas per section (total 2 brain sections
per mice) from two independent experiments (n = 4 per group). *P <0.05. (C) Brain viral load was determined in WT and db/db mice, at days 4, 6,
and 8 after infection by plaque assay using Vero cells and is reported as PFU per gram of tissue. Data represents the mean ± SEM, representing
two independent experiments (n = 7-11 per group). *P <0.05. PFU, plaque-forming units; SEM, standard error of mean.
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infection in WT mice, which further increased at day 8
after infection as compared to corresponding controls
(Figure 2A, 2C, and 2D). However, this increase was at-
tenuated in the brain of infected db/db mice. Expression
levels of CD45, CD8 and CD11b genes were significantly
low in infected db/db mice when compared with infected
WT mice at both days 6 and 8 after infection (P <0.05).
No significant difference in the expression of CD4 was
observed between both groups (Figure 2B).
To further verify these results we isolated leukocytes
from the brain of WT and db/db mice at day 8 after infec-
tion and analyzed by flow cytometry. We stained the cells
for CD45+, CD11b+, CD3+, CD4+ and CD8+ markers to
analyze both T cells and non-T cell subpopulations. Con-
sistent with the mRNA, histological analysis and immuno-
histochemistry results, there was a significant reduction in
leukocyte infiltration in the brain of WNV-infected db/db
mice when compared to WT mice. As shown in Figure 3A,
the percentage of CD3+CD8+T cells in the brain of db/db
mice was lower than in those of WT mice (3.9 versus
11.6%). Additionally, the percentage of CD45+CD3- leuko-
cytes was reduced in the db/db mice more so than in the
WT mice (46.6 versus. 54.8%). Finally, the total number of
CD3+CD8+ T and CD45+CD3- cells trafficking into the
brain of infected db/db mice was also significantly lower
than in the infected WT mice (Figure 3C) (P <0.05). No
statistically significant difference between the percentagesFigure 2 WNV-induced leukocyte migration in the brain of WT and db
WNV-infected brains from WT and db/db mice at indicated time points to d
gene expression. Changes in the levels of each gene were first normalized
was calculated in comparison to corresponding mock-infected brain. Data re
(n = 7 per group). *P <0.05. SEM, standard error of mean.or numbers of CD3+CD4+ T and CD45+CD11b+ cells in
the brains of WTand db/db mice was identified.
Furthermore, we isolated leukocytes from the spleens
of WT and db/db mice at day 8 after infection. Unlike
the brain, equivalent percentage and numbers of CD3+
CD4+ and CD3+CD8+ T cells, CD45+CD3- cells as well
as CD45+CD11b+ cells were observed in the spleens of
WT and db/db mice (Figure 3B and 3D).
Expression of chemokines and their receptors in the
brains of db/db mice after WNV infection
The migration of leukocytes into WNV-infected brain is
associated with increased expression of several chemo-
kines and their receptors in the brain [25]. It has been
demonstrated that WNV-induced expression of chemo-
kines such as CCL2, CXCL10 and chemokines receptors
such as CCR5 and CCR2 promote the trafficking of leu-
kocytes into the brain [25,29,39,40]. To determine
whether decreased leukocyte accumulation in the brains
of db/db mice could be indirectly attributed to the
reduced expression of these chemokines in the brains of
db/db mice, we analyzed the differential expression of
various chemokines and their receptors in the brains
of WTand db/db mice after WNV infection. mRNA levels
of chemokines and their receptors were measured at day 8
after infection using a PCR array. WNV infection resulted
in a dramatic increase in mRNA levels of key chemokines
and their receptors in the brain of WT mice as compared/db mice. qRT-PCR was conducted on RNA extracted from mock- and
etermine fold-change in (A) CD45, (B) CD4, (C) CD8 and (D) CD11b
to the β-actin gene and then the fold-change in WNV-infected brain
presents the mean ± SEM, representing two independent experiments
Figure 3 Flow cytometric analysis of leukocyte infiltration in the brains and spleens of WNV-infected WT and db/db mice. WT and db/db
mice were infected with 10 PFU of WNV, and brains and spleens were harvested after extensive perfusion at day 8 after infection. Brain and
spleen leukocytes were isolated and analyzed by flow cytometry. (A and B) Representative flow cytometry profiles demonstrating percentage of
CD3+CD4+ T cells, CD3+CD8+ T cells, CD45+CD3- leukocytes and CD45+CD11b+ cells in the brain and spleen at day 8 after infection in WT and
db/db mice. Data represents two independent experiments (n = 6 per group). (C and D) Total number of CD3+CD4+ T cells, CD3+CD8+ T cells,
CD45+CD3- leukocytes and CD45+CD11b+ cells per brain and spleen were calculated. Data represents the mean ± SEM, representing two
independent experiments (n = 6 per group). *P <0.05. PFU, plaque-forming units; SEM, standard error of mean.
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mice, maximum increase of 113-, 279-, 394-, and 641-fold
was observed in the levels of CCL5, CCL2, CXCL9, and
CXCL10 respectively. Moreover, there was almost 10-fold
increase in the mRNA levels of these chemokines in the
brain of infected db/db mice when compared to infected
WT mice. The mRNA expression of chemokines receptors
such as CCR1, CCR5, CCR7 and CXCR2 was also in-
creased in the brains of infected db/db mice when com-
pared to infected WT mice (Table 2). Similar to the
mRNA expression, protein levels of the key chemokines
such as CXCL10, CXCL1, CCL2, CCL5, CCL3, and G-
CSF were increased in the brains of infected WT mice
as measured by the multiplex immunoassay (Figure 4A-F).
However, their levels were significantly elevated in the
brains of db/db mice when compared to WT mice at
day 8 after infection (P <0.05). Very low levels of
these chemokines were detected in mock-infected
mice. Moreover, there was no significant difference in
the chemokine levels between mock-infected WT and
db/db mice (Figure 4A-F).
Expression of CAM in the brains of db/db mice after WNV
infection
WNV infection induces the expression of CAM such as
ICAM-1, VCAM-1, and E-selectin, to facilitate leukocyte
trafficking into the brain [31,36,41,42]. Since differences
in leukocyte migration were observed, we analyzed theTable 2 *Expression of chemokines and their receptors in
the brain of WNV-infected WT and db/db mice at day 8
after infection
Ligand WT db/db Receptor WT db/db
CCL1 -2.1 1.1 CCR1 6.1 10
CCL2 279 320 CCR3 5.0 4.4
CCL3 17 260 CCR5 2.2 5.0
CCL4 20 260 CCR7 3.8 8.1
CCL5 113 279 CXCR2 5.0 4.7
CCL7 86 243 CXCR3 -1.8 2.5










*Changes in the levels of each gene was first normalized to the housekeeping
genes and then the fold-change in WNV-infected brains was calculated in
comparison to corresponding mock-infected brains.mRNA and protein expressions of E-selectin, ICAM-1,
and VCAM-1 in the brain of WT and db/db mice after
WNV infection. As anticipated, a 10- to 25-fold increase
in the mRNA expression of ICAM-1 and E-selectin were
observed in the brains of WT mice compared to corre-
sponding mock-infected mice at day 8 after infection
(Figure 5A). In contrast, a modest three to seven-fold in-
crease in the mRNA expression of ICAM-1 and E-selectin
were observed in the brains of infected db/db mice com-
pared to corresponding mock-infected mice. The mRNA
expression of both E-selectin and ICAM-1 was signifi-
cantly less in the infected db/db mice than in infected WT
mice (P <0.05). However, there was no significant increase
in the expression of VCAM-1 in both WTand db/db mice
after infection. Similar to mRNA expression, western blot-
ting further demonstrated the increase in the protein ex-
pression of both E-selectin and ICAM-1 in the brains of
WT mice at day 8 after infection. However this increase
was markedly reduced in the brains of infected db/db mice
(Figure 5B). As seen in Figure 5C, the increase in the ex-
pression of ICAM-1 and E-selectin was 250 to 300% in
WT mice and 120 to 130% in db/db mice, compared with
corresponding mock-infected mice. The protein levels of
both E-selectin and ICAM-1 were significantly lower in
the infected db/db mice when compared to infected WT
mice (P <0.05). Moreover, immunohistochemical analysis
revealed markedly reduced staining of E-selectin and
ICAM-1 in the brains of db/db mice when compared
with WT mice at day 8 after infection (Figure 6). Fur-
thermore, increased expression of CAM in WT mice
co-localized with endothelial cells (Figure 6).
Similar to the mRNA data, there was no significant in-
crease in the protein expression of VCAM-1 in both WT
and db/db mice after WNV infection (Figures 5 and 6).
Expression of cytokines and their receptors in the brains
of db/db mice after WNV infection
WNV infection is associated with increased expression of
several pro-inflammatory cytokines in the brain [25,43].
WNV-induced expression of pro-inflammatory cytokines
such as IL-1β and TNF regulate leukocyte trafficking into
the brain, and neuronal death after infection [32,38]. Dia-
betes is also associated with an enhanced inflammatory re-
sponse to infections [6,7]. Consequently, we examined the
expression levels of these key pro-inflammatory cytokines
in the brains of WT and db/db mice after WNV infection.
WNV infection resulted in a 3- to 10-fold increase in the
mRNA expression of cytokines such as IL-1β, TNF and
IFNγ in the brains of WT mice at day 8 after infection
compared to corresponding mock-infected mice (Table 3).
In contrast, there was an 11- to 113-fold increase in ex-
pression of the aforementioned cytokines in the brains of
infected db/db mice compared to corresponding mock-
infected mice. We also observed a 8-fold increase in the
Figure 4 Chemokines levels in the brains of WT and db/db mice after WNV infection. Brains were harvested from WT and db/db mice at
indicated time points and homogenized as described in the Materials and methods section. Levels of chemokines as noted in the figure (A) CXCL10,
(B) CXCL1, (C) CCL2, (D) CCL5, (E) CCL3, (F) G-CSF were measured using multiplex immunoassay and are expressed as the mean concentration
(pg/g of tissues) ± SEM, representing two independent experiments (n = 7 per group). *P <0.05. SEM, standard error of mean.
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expression of cytokines in the brain of WT and db/db
mice was concomitantly associated with an increase in the
expression of their corresponding receptors. The mRNA
expression of IL1R2 and TNFRSF1B was increased by
4- and 2-fold, respectively, in WT mice at day 8 after
infection (Table 3). In db/db mice, similar to increased
cytokine levels, there was a 4- to 9-fold up-regulation of
mRNA expression of their receptors (Table 3). Similar to
the mRNA expression, protein levels of IL-1β, TNF, IL-6,
IFNγ, and IL-1α were also significantly elevated in the
brains of db/db mice when compared to WT mice at
day 8 after infection as measured by the multiplex im-
munoassay (Figure 7A-F) (P <0.05). However, IL-13 levels
did not differ between WT and db/db mice (Figure 7F).
Very low levels of these cytokines were detected in mock-
infected mice, moreover, there was no significant differencein the cytokine levels between mock-infected WT and
db/db mice (Figure 7A-F).
Activation of astrocytes in db/db mice after WNV infection
Astrocytes produce a wide variety of chemokines and cy-
tokines upon exposure to pro-inflammatory stimuli. Since
changes were observed in the chemokines and cytokines
and taking into account the fact that activation of astro-
cytes is one of the major hallmarks of WNV infection
[26], we next investigated the activation of astrocytes in
WT and db/db mice at days 6 and 8 after WNV infec-
tion. The mRNA expression of GFAP was increased in
WT mice at day 8 after infection compared to corre-
sponding mock-infected mice. However, the increase in
the GFAP expression was significantly higher in the
infected db/db mice when compared to the infected
WT mice (Figure 8A) (P <0.05). Similar to the mRNA
Figure 5 WNV-induced CAM expression in the brains of WT and db/db mice. (A) qRT-PCR was conducted on RNA extracted from mock- and
WNV-infected brains from WT and db/db mice at indicated time points to determine the fold-change in E-selectin, ICAM-1, and VCAM-1 gene expression.
Changes in the levels of each gene were first normalized to the β-actin gene, and then the fold-change in WNV-infected brains was calculated
in comparison to corresponding mock-infected brains. Data represents the mean ± SEM, representing two independent experiments (n = 7 per
group). *P <0.05. (B) The protein levels of E-selectin, ICAM-1 and VCAM-1 were analyzed using Western blot analysis. Total brain lysates were
separated by SDS-PAGE, transferred onto nitrocellulose membranes and immunoblotted with antibodies specific to E-selectin, ICAM-1, and
VCAM-1. Equal loading was confirmed by re-probing with anti-β-actin antibody and the bands were detected using the Li-Cor Odyssey infrared
method. (C) Quantitative analysis of Western blots results. Changes in the levels of each gene was first normalized to the β-actin gene and then
the percentage increase in WNV-infected brains was calculated in comparison to corresponding mock-infected brains. Data represents the
mean ± SEM, representing two independent experiments (n = 7 per group). *P <0.05. ICAM-1, intercellular cell adhesion molecule 1; VCAM-1,
vascular cell adhesion molecule 1; SEM, standard error of mean.
Kumar et al. Journal of Neuroinflammation 2014, 11:80 Page 10 of 17
http://www.jneuroinflammation.com/content/11/1/80expression, immunohistochemical analysis revealed in-
creased GFAP expression in the WT mice at day 8 after
infection. However GFAP immunoreactivity was more
pronounced in the brain of db/db mice (Figure 8B).
Neuronal death in db/db mice after WNV infection
Neuronal death is the hallmark of WNVE [44]. There-
fore, we further evaluated the extent of neuronal death
in the brains of WT and db/db mice after WNV infec-
tion. We examined H & E-stained sections of brain
tissues from WT and db/db mice at day 8 after WNV
infection. The neurons of db/db mice demonstrate eo-
sinophilic cytoplasm and nuclear karyorrhexis, indicative
of neuronal death, while neurons of WT mice from thesame area of the brain are better preserved with baso-
philic cytoplasm and round nuclei (Figure 8C). WNV-
induced neuronal apoptosis was further evaluated by
direct TUNEL staining of WT and db/db brain tissues
at day 8 after infection. TUNEL staining demonstrated
markedly increased TUNEL-positive cells in the brain
of db/db mice when compared to WT mice (Figure 8D).
All the TUNEL-positive cells co-localized with NeuN
(neuronal cell marker) (Figure 8F). Furthermore, we
quantitated TUNEL-positive cells in the brain sections
from four different mice in each group. The number of
TUNEL-positive cells in the inflected db/db mice were
significantly higher than in infected WT mice (Figure 8E)
(P <0.05).
Figure 6 Immunohistochemical analysis of CAM in the brains of WT and db/db mice after WNV infection. Cryopreserved brain sections
from WNV-infected WT and db/db mice at day 8 after infection were stained with antibodies against E-selectin, ICAM-1, VCAM-1 (Red), and vWF
(Green). The photomicrographs demonstrate representative images obtained from two independent experiments (n = 4 per group). Bars, 20 μm.
ICAM-1, intercellular cell adhesion molecule 1; VCAM-1, vascular cell adhesion molecule 1; vWF, von Willebrand factor.
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One of the hallmarks of WNVE is the accumulation of
immune cells. The infiltration of immune cells is asso-
ciated with increased production of neuroinflammatory
molecules such as cytokines and chemokines and requires
up regulation of CAM. In contrast, we demonstrate thatWNVE in db/db mice is characterized by the reduced ac-
cumulation of leukocytes, despite increased production of
pro-inflammatory cytokines and chemokines, and is asso-
ciated with attenuated expression of CAM, increased brain
viral load, activation of astrocytes, and enhanced neuronal
death. These results, in conjunction with our previously
Table 3 *Expression of cytokines and their receptors in
the brains of WNV-infected WT and db/db mice at day 8
after infection
Ligand WT db/db Receptor WT db/db
IFNγ 10 113 IL1R1 1.5 1.5
IL-1α 1.8 8.1 IL1R2 4.4 9.4
IL-1β 3.3 11 TNFRSF1A 1.8 7.1
TNF 6.1 92 TNFRSF1B 2.3 4.1
IL-4 -2.1 -4.2
*Changes in the levels of each gene was first normalized to the housekeeping
genes, and then the fold-change in WNV-infected brains was calculated in
comparison to the corresponding mock-infected brains.
Figure 7 Cytokines levels in the brains of WT and db/db mice after W
indicated time points and homogenized as described in the Materials and
(B) TNF, (C) IL-6, (D) IFNγ, (E) IL-1α, and (F) IL-13 were measured using mu
(pg/g of tissues) ± SEM, representing two independent experiments (n = 7
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mune cells leads to reduced virus clearance from the
brain, resulting in high mortality in WNV-infected db/db
mice [19].
Reduced leukocyte infiltration in the brains of db/db mice
WNVE is characterized by virus-associated pathological
processes, including reaction of the brain resident cells
and infiltration of inflammatory leukocytes, primarily
monocytes and T cells, in the perivascular space and
parenchyma, [25,29]. While infiltration of monocytes is
protective, it also contributes to WNV-associated path-
ology [39,40,45]. T cells play an important role in protect-
ing the host against WNV infection. While CD4+ T cells
respond primarily in the periphery, CD8+ T cells migrateNV infection. Brains were harvested from WT and db/db mice at
methods section. Levels of cytokines as noted in the figure (A) IL-1β,
ltiplex immunoassay and are expressed as the mean concentration
per group). *P <0.05. SEM, standard error of mean.
Figure 8 Astrocyte activation and neuronal apoptosis in the brains of WT and db/db mice. (A) qRT-PCR was conducted on RNA extracted
from mock- and WNV-infected brains from WT and db/db mice at day 6 and 8 after infection to determine fold-change in GFAP gene expression.
Change in the levels of GFAP gene was first normalized to the β-actin gene and then the fold-change in WNV-infected brains was calculated in
comparison to the corresponding mock-infected brains. Data represents the mean ± SEM, representing two independent experiments (n = 7 per
group). *p <0.05. (B) Cryopreserved brain sections from WNV-infected WT and db/db mice at day 8 after infection were stained for GFAP.
Immunoreactivity of GFAP was higher in WNV-infected db/db mice. The photomicrographs demonstrate representative images obtained from
two independent experiments (n = 4 per group). Bars, 20 μm. (C) Cryopreserved brain sections from WNV-infected WT and db/db mice at day 8
after infection were stained with H & E. Black arrows identify neurons. (D) TUNEL assay was conducted on cryopreserved brain sections from
WNV-infected WT and db/db mice at day 8 after infection to evaluate neuronal apoptosis (Green, white arrows and enlarged inset of the arrowed
box). The photomicrographs demonstrate representative images obtained from two independent experiments (n = 4 per group). Bars, 20 μm.
(E) Quantitative representation of TUNEL-positive cells from 15 different brain areas per section (total 2 brain sections per mice) from two
independent experiments (n = 4 per group). Number of TUNEL-positive cells were significantly higher in the brain of db/db mice. *P <0.05.
(F) Co-immunostaining of TUNEL-positive cells with NeuN (neuronal cell marker). The photomicrographs demonstrate representative images
obtained from two independent experiments (n = 4 per group). GFAP, glial fibrillary acidic protein; TUNEL, Terminal deoxynucleotidyl transferase
dUTP nick end labeling; SEM, standard error of mean.
Kumar et al. Journal of Neuroinflammation 2014, 11:80 Page 13 of 17
http://www.jneuroinflammation.com/content/11/1/80
Kumar et al. Journal of Neuroinflammation 2014, 11:80 Page 14 of 17
http://www.jneuroinflammation.com/content/11/1/80into the brain and clear WNV from infected neurons [43].
CD8+ T cells utilize perforin- and Fas ligand-dependent
cytolytic mechanisms to limit WNV infection [46,47].
These cytolytic clearance mechanisms by effector CD8+ T
cells limit viral burden and neurological disease, and
outweigh the possible pathological effects of immune-
targeted neuronal injury by CD8+ T cells. It has been dem-
onstrated that mice lacking CD8+ T cells have increased
viral burden in the brain and mortality rate when infected
with WNV [30,46,47]. Similar to the previously published
data, we demonstrate that brain WNV titer in db/db mice
was significantly higher than in WT mice (Figure 1C) [19].
Although we also observed a delay in the induction of
IFN-α response in the brains of db/db mice, IFN-α levels
were similar in the brains of WT and db/db mice at day 8
after infection [19]. Moreover, as described above, adaptive
immune responses (particularly T cell mediated immunity)
is a predominant immune response and is essential for
controlling WNV infection in the brain. In this study, we
used a variety of experimental approaches to demonstrate
that WNV-infected db/db mice had reduced levels of infil-
trating CD45+ and CD8+ cells in the brain when compared
to infected WT mice (Figures 1, 2, 3). Although several
peripheral responses including antiviral immune responses
(IFN-α, IgM, and IgG) and pro-inflammatory responses,
were altered in the WT and db/db mice [19], we observed
a similar number of immune cells including CD8+ T
cells in the spleen of WNV-infected WT and db/db mice
(Figure 3).
It is known that the diabetic condition reduces leukocyte
adherence and transmigration [48,49]. Several in vitro
studies have demonstrated significantly reduced trans-
migration of neutrophils and monocytes in response to
various chemotactic stimuli across an in vitro transwell
chamber or Boyden chamber in diabetic patients com-
pared to non-diabetic controls [3,8,9,49,50]. Recently,
an in vivo study using db/db mice revealed reduced in-
filtration of neutrophils in the brain after LPS adminis-
tration [10]. Moreover, it has also been demonstrated
that reduction in rolling, adhesion, and migration of
leukocytes to the site of infection increased susceptibil-
ity of diabetic mice to polymicrobial sepsis [49]. Simi-
larly, in our study, the presence of diabetes significantly
alters leukocyte recruitment in the brain, resulting in a
failure to clear WNV infection in the brains of db/db
mice.
Enhanced inflammation in the brains of db/db mice
despite reduced leukocyte infiltration
WNV-induced expression of pro-inflammatory mole-
cules such as CXCL10, CCL2 and TNF are essential for
the trafficking of leukocytes into the brain [29,32,39].
Increased expression of cytokines and chemokines in a
WNV-infected brain is usually associated with theenhanced trafficking of leukocytes into the brain [43].
We observed an increase in the various chemokine and
cytokine levels in the brains of db/db mice despite reduced
leukocyte infiltration (Figures 4 and 7, Tables 2 and 3). This
effect may be due to the absence of CD8+ T cells which
may lead to uncontrolled virus replication in resident
brain cells, such as neurons and astrocytes, resulting in
the increased production of cytokines and chemokines.
It has been demonstrated that WNV-infected neurons
directly contribute to the inflammation by secreting
various chemokines and cytokines [29,38]. Moreover,
the activation of astrocytes is one of the key pathogenic
features of WNVE [26,51]. WNV-induced increased
production of cytokines and chemokines has been dem-
onstrated in the astrocytes [52-54]. In this study, we
also demonstrate an increase in astrocytes activation in
the brains of db/db mice when compared to WT mice
(Figure 8A and B). These results suggest that WNV-
infected neurons and activated astrocytes are the potential
source of these inflammatory molecules in the brains of
db/db mice. However, our data do not rule out the possi-
bility of cytokine production by infiltrating NK cells and/
or resident microglial cells in the brains of db/db mice.
Moreover, fewer immune cells infiltrating into the brains
of db/db mice may be hyperresponsive and producing
increased amounts of pro-inflammatory mediators in the
brains of these mice. Similarly, in our previous study, we
also observed increased production of pro-inflammatory
mediators in the serum of db/db mice when compared to
WT mice [19]. These data collectively demonstrate that
WNV infection in db/db mice led to the increased pro-
duction of inflammatory mediators, both in the periphery
and in the brain.
Attenuated WNV-induced CAM expression in the brains of
db/db mice
The other possible explanation for the reduced leukocyte
migration observed in the brains of WNV-infected db/db
mice is the expression of CAM. CAM are required for
leukocyte migration into the brain [55]. WNV infection
also increases the expression of CAMs such as ICAM-1,
VCAM-1, and E-selectin, to facilitate leukocyte trafficking
into the brain parenchyma [31,41,42]. It has been demon-
strated that CAM are important for maintaining leuko-
cytes in the brain following WNV infection. Moreover,
leukocyte and macrophage infiltrates were decreased in
the brains of ICAM-1-/- mice after WNV infection [31].
Similarly, we observed an increased expression of ICAM-1
and E-selectin in the brains of WT mice after WNV infec-
tion, which correlates with leukocyte infiltration in these
mice (Figures 5 and 6). Similar results have also been ob-
served in other CNS-tropic viruses such as Theiler’s mur-
ine encephalomyelitis virus (TMEV) [56]. It has been
demonstrated that TMEV infection induces the expression
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which plays an important role in mediating the infiltration
of leukocytes into the brain [56-58].
In our study, significant up-regulation of CAM is ob-
served at day 8 after infection in the brain of WT mice,
which correlates with high virus replication (Figure 1C)
[19]. In contrast, levels of both E-selectin and ICAM-1
were significantly lower in the brains of infected db/db
mice despite a significantly high viral load in the brains
of db/db mice when compared to WT mice (Figures 1C
and 5). It has been demonstrated that patients with Type
2 diabetes exhibit an attenuated upregulation of ICAM-1,
VCAM-1, and E-selectin after various stimuli such as LPS
[3,11]. A recent study has demonstrated that the reduced
expression of ICAM-1 plays a crucial role in decreased
neutrophils recruitment into the brains of db/db mice
after LPS-induced systemic inflammation [10]. Similarly,
in WNV-infected db/db mice, reduced levels of CAM are
insufficient to allow efficient leukocyte migration during
WNVE despite high chemokines levels in the brain.
Increased neuronal death in db/db mice
WNV-induced pro-inflammatory cytokines are known
to modulate BBB permeability, activate glial cells, and
mediate neuronal death, leading to the induction of
lethal encephalitis [38,59,60]. In this study, we demon-
strate significantly elevated levels of cytokines such as
IL-1β, IL-6, TNF, IL-1α, and IFN-γ and their receptors
in the brains of db/db mice at days 6 and 8 after WNV
infection (Figure 7, Table 3), which correlated with in-
creased levels of WNV in the brains of db/db mice [19].
IL-1β and TNF have been demonstrated to induce neur-
onal apoptosis after WNV infection [38]. Similarly, we also
observed increased neuronal apoptosis in the brains of
db/db mice when compared to WT mice (Figure 8C-F).
Neuronal apoptosis is the hallmark of WNVE and an
increase in neuronal apoptosis is associated with in-
creased lethality following WNV infection [24,44]. Col-
lectively, these results indicate a correlation between
enhanced inflammatory response and increased neuronal
apoptosis in the brains of db/db mice, thereby leading
to increased mortality. These data are consistent with
previous observations that db/db mice demonstrate a
greater inflammatory response to various pathogens such
as Staphylococcus aureus, Porphyromonas gingivalis, and
Trypanosoma cruzi, in which a heightened inflamma-
tory response was correlated with increased disease
severity [7,61,62].
Conclusions
Our previously published data demonstrated that the
presence of diabetes attenuated peripheral antiviral im-
mune responses leading to an increased WNV load in
the serum, peripheral tissues, and brain [19]. In thisstudy, we demonstrate that the presence of diabetes en-
hances WNV infection in the brain by inhibiting migra-
tion or accumulation of protective leukocytes in the brain,
which correlates with reduced levels of CAM. Enhanced
virus replication leads to increased levels of chemokines
and cytokines in the brains of db/db mice, which mediates
astrocytes activation and causes neuronal death, leading to
lethal encephalitis and increased mortality in db/db mice.
Collectively, these data and our previously published data
[19] build the foundation for the development of a much
needed therapeutic intervention to limit the progression
of WNVE among diabetics.
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